India approves further trials for first homegrown mRNA COVID-19 shot

India has approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine developed by Gennova Biopharmaceuticals Ltd, the government said on Tuesday, after the shot was found to be safe and effective in an early-stage study.

Gennova is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot. These vaccines do not use a live virus to generate an immune response but prompt the human body to make a protein that triggers one.

Leave a Reply

Your email address will not be published. Required fields are marked *

India approves further trials for first homegrown mRNA COVID-19 shot

India has approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine developed by Gennova Biopharmaceuticals Ltd, the government said on Tuesday, after the shot was found to be safe and effective in an early-stage study.

Gennova is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot. These vaccines do not use a live virus to generate an immune response but prompt the human body to make a protein that triggers one.

Leave a Reply

Your email address will not be published. Required fields are marked *

India on Tuesday approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine, being developed by Gennova Biopharmaceuticals, after the shot was found to be safe and effective in an early-stage study.

The country has authorised emergency use for two domestically developed COVID-19 shots, made by Bharat Biotech and Zydus Cadila , but does not have mRNA-based vaccines yet in its immunisation programme ahead of a potential third coronavirus wave.

Leave a Reply

Your email address will not be published. Required fields are marked *

India on Tuesday approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine, being developed by Gennova Biopharmaceuticals, after the shot was found to be safe and effective in an early-stage study.

The country has authorised emergency use for two domestically developed COVID-19 shots, made by Bharat Biotech and Zydus Cadila , but does not have mRNA-based vaccines yet in its immunisation programme ahead of a potential third coronavirus wave.

Leave a Reply

Your email address will not be published. Required fields are marked *